Riskpilot← Back to searchSign inGet full accessMycometer A/S
A/SActiveCVR 41951567Dr Neergaards Vej 3Research and experimental development on natural sciences and engineering · NACE 7210Est. 202015 employees
Revenue 2025
DKK 5,9M
-31% vs 2024
EBITDA margin
26.2%
-66% vs 2024
Equity ratio
78.7%
Financial strength
Net profit 2025
DKK -2,9M
-225% vs 2024
| Revenue | DKK 5,9M | -31% |
| EBITDA | DKK 1,5M | -66% |
| Net profit | DKK -2,9M | -225% |
| Total assets | DKK 11,6M | -33% |
| Equity | DKK 9,1M | -37% |
| Employees | 15 | — |
Legal name
Mycometer A/S
CVR number
41951567
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
17. december 2020
Share capital
DKK 400.000
Employees
15 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed med fremstilling og salg af mikrobiologiske metoder til måling af mikrobiel kontaminering, og dermed beslægtet virksomhed.
Address
Dr Neergaards Vej 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | 5.643 | 5.341 | 6.440 | 5.923 | 8.526 | 5.902 |
| Staff expenses | -2.032 | -2.616 | -3.790 | -4.113 | -3.987 | -4.356 |
| EBITDA | -739 | 2.725 | 2.650 | 1.810 | 4.538 | 1.546 |
| Depreciation & amort. | -1.555 | -1.584 | -1.599 | -1.552 | -1.540 | -1.546 |
| EBIT | -2.294 | 1.141 | 1.052 | 259 | 2.998 | 0 |
| Net financials | -372 | 462 | 266 | -735 | 42 | -2.939 |
| Profit before tax | -2.666 | 1.603 | 1.317 | -476 | 3.040 | -2.939 |
| Tax | -593 | 206 | 297 | 60 | 704 | -12 |
| Net profit | -2.072 | 1.398 | 1.020 | -536 | 2.335 | -2.927 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 20.193 | 19.746 | 19.923 | 18.318 | 17.267 | 11.597 |
| Equity | 14.238 | 15.636 | 16.655 | 15.120 | 14.455 | 9.128 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3.236 | 1.543 | 1.032 | 1.304 | 1.218 | 1.204 |
| Total debt | 3.236 | 1.543 | 1.032 | 1.304 | 1.218 | 1.204 |
EBITDA margin
26.2%
This company
15.8%
Market median
+66% vs market
20202025
Equity ratio
78.7%
This company
38.2%
Market median
+106% vs market
20202025
Return on equity
-32.1%
This company
18.4%
Market median
-274% vs market
20202025
Net profit margin
-49.6%
This company
8.1%
Market median
-712% vs market
20202025
Asset turnover
0.51×
This company
1.12×
Market median
-54% vs market
20202025
Debt / equity
0.27×
This company
0.62×
Market median
+56% vs market
20202025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MA Management | Management | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
OPUS FUNGUS ApS | Company | 25.0% | 25.0% | 2024 |
MVA & CO HOLDING ApS | Company | 25.0% | 25.0% | 2020 |
Myconid ApS | Company | 20.0% | 20.0% | 2024 |
Mycotopia ApS | Company | 20.0% | 20.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MVA & CO HOLDING ApS
Mycometer A/S Board members of Mycometer A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Morten Anders Ulsøe Reeslev | Management | 0 companies |
| Jens Lassen | Board of Directors | 0 companies |
| Henrik Skaanderup | Chairman | 0 companies |